Market capitalization | SEK9.64b |
Enterprise Value | SEK14.33b |
P/E (TTM) P/E ratio | 19.05 |
EV/FCF (TTM) EV/FCF | 10.29 |
EV/Sales (TTM) EV/Sales | 1.28 |
P/S ratio (TTM) P/S ratio | 0.86 |
P/B ratio (TTM) P/B ratio | 1.23 |
Dividend yield | 2.54% |
Last dividend (FY23) | SEK0.90 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
8 Analysts have issued a Arjo forecast:
8 Analysts have issued a Arjo forecast:
Sep '24 |
+/-
%
|
||
Revenue | 11,182 11,182 |
4%
4%
|
|
Gross Profit | 4,500 4,500 |
9%
9%
|
|
EBITDA | 2,080 2,080 |
8%
8%
|
EBIT (Operating Income) EBIT | 1,020 1,020 |
30%
30%
|
Net Profit | 506 506 |
30%
30%
|
In millions SEK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Arjo AB engages in the provision of medical devices and solutions. It operates in the following geographical segments: North America, Western Europe, and Rest of the World. It offers products within the areas of patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention, and diagnostics. The company was founded by Arne Johansson in 1957 and is headquartered in Malmo, Sweden.
Head office | Sweden |
CEO | Karl Lindoff |
Employees | 6,798 |
Founded | 1957 |
Website | www.arjo.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.